Key result
Preimplantation genetic testing enables delivery of a healthy infant in lethal TTN mutation carriers.
Why the study?
Does in vitro fertilization with preimplantation genetic testing prevent the transmission of fatal TTN gene mutations in a carrier couple?
Case Report (n=2)
No
Does in vitro fertilization with preimplantation genetic testing prevent the transmission of fatal TTN gene mutations in a carrier couple?
IVF with preimplantation genetic testing successfully prevented the transmission of fatal TTN gene mutations in a carrier couple, resulting in a healthy birth.
Successful PGT delivery in one TTN carrier couple; extends preimplantation testing to fatal myopathies but remains hypothesis-generating.
Severe congenital myopathy with fatal cardiomyopathy (EOMFC) is a rare genetic neuromuscular disorder inherited in an autosomal recessive manner. Here we presented a successful pregnancy obtained by in vitro fertilization (IVF) using preimplantation genetic testing (PGT) in one young Romanian carrier couple that already lost mutation(s) within the TNN gene and whose first baby passed away due to multiple complications. It was delivered via emergency C-section at 36 weeks and fully dependent on artificial ventilation for a couple of months, weighing 2200 g and an APGAR score of 3. The aCGH + SNP analysis revealed an abnormal profile of the first newborn; three areas associated with loss of heterozygosity on chromosome 1 (q25.1-q25.3) of 6115 kb, 5 (p15.2-p15.1) of 2589 kb and 8 (q11.21-q11.23) of 4830 kb, a duplication of 1104 kb on chromosome 10 in the position q11.22, and duplication of 1193 kb on chromosome 16 in the position p11.2p11.1. Subsequently, we proceeded to test the parents and showed that both parents are carriers; confirmed by Sanger and NGS sequencing-father-on Chr2(GRCh37):g.179396832_179396833del-TTN variant c.104509_104510del p.(Leu34837Glufs*12)-exon 358 and mother-on Chr2(GRCh37):g.179479653G>C-TTN variant c.48681C>G p.(Tyr16227*)-exon 260. Their first child died shortly after birth due to multiple organ failures, possessing both parent's mutations; weighing 2200 g at birth and received an APGAR score of 3 following premature delivery via emergency C-section at 36 weeks. Two embryos were obtained following the IVF protocol; one possessed the mother's mutation, and the other had no mutations and was normal (WT). In contrast with the first birth, the second one was uneventful. A healthy female baby weighing 2990 g was delivered by C-section at 38 weeks, receiving an APGAR score of 9.
No takes yet. Share an insight, caveat, or question.
Doroftei et al. (2021) conducted a case report in Carriers of mutations in the TTN gene (EOMFC) (n=2). In vitro fertilization using preimplantation genetic testing (IVF-PGT) vs. Previous unassisted pregnancy (historical) was evaluated on Delivery of a healthy infant without the targeted mutations. In vitro fertilization using preimplantation genetic testing successfully led to the delivery of a healthy infant for a couple carrying lethal mutations in the TTN gene.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: